$KN

KN Q2 Deep Dive: Precision Devices Drive Growth Amid Robust Bookings and Margin Expansion

Knowles reported Q2 revenue of $166.8M, up 14.3% year over year and above analysts’ $157M estimate. Adjusted EPS was $0.33 vs $0.31 expected, and adjusted EBITDA was $41.8M with margin expansion. Q3 CY2026 guidance calls for $172M revenue and $0.36 adjusted EPS at midpoint, both above estimates, with operating margin rising to 14.9%.

Original reporting
Published Jul 27, 2026, 2:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 27, 2026, 2:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
KN Q2 Deep Dive: Precision Devices Drive Growth Amid Robust Bookings and Margin Expansion — source image
Decision brief

The 30-second read

$KNBullishMed
01

Why it matters

The newest actionable elements are the reported Q2 beats and the raised Q3 CY2026 guidance, supported by sustained bookings strength (book-to-bill >1.4) and operating margin expansion.

02

Market read

Traders can update near-term expectations using the explicit Q3 midpoint guidance and margin expansion narrative tied to bookings durability.

03

What to watch

The article emphasizes pricing power and capacity utilization, but does not quantify backlog duration, customer concentration, or potential supply-chain constraints that could affect follow-through.

Relevance 8/10Novelty 7/10Timing: post-earnings, ahead of Q3 CY2026 execution

Background

The piece is a Q2 earnings deep dive for Knowles, focusing on segment demand (precision devices, defense, medtech/specialty audio) and margin drivers.

Company-level read

Ticker impact

$KNBullishHigh confidence
Context

Knowles reported Q2 revenue and EPS beats, raised Q3 guidance, and cited a book-to-bill above 1.4 for seven straight quarters.

Expected impact

Moderately positive bias for the next few sessions as traders reprice Q3 revenue/EPS and margin trajectory.

Evidence & confidence

The article provides specific Q2 results (revenue, adjusted EPS, EBITDA) and explicit Q3 midpoint guidance above consensus, plus a sustained bookings metric (book-to-bill >1.4) and operating margin expansion.

Market effects

Strength in precision devices and defense electronics demand may reinforce positive read-through for suppliers tied to medtech, defense electronics, and industrial electrification.

Limited explicit regional detail, but defense spending references can support broader defense electronics sentiment.

Defense and electronic warfare demand cited as drivers, which can influence global defense supply-chain expectations.

Counterpoint

Guidance upside may already be partially priced; margin expansion could face pressure if capacity investments or mix shifts do not sustain gross margin gains.

Key entities

  • Knowles

    Reported Q2 results, raised Q3 guidance, and attributed growth to precision devices demand and defense electronics orders.

  • Jeffrey Niew

    CEO cited a $15 million multiyear radar order and described customer capacity commitments.

  • John Anderson

    CFO discussed gross margin improvement drivers including pricing, product mix, and capacity utilization.

Related articles

$KNMed

Knowles Targets 30% Margins as Specialty Components Drive Growth

Knowles Corporation (KN) aims for 30% EBITDA margins within 36 months, driven by growth in specialty components. The company reported 11% EBITDA growth from 2017-2025, with recent organic growth exceeding 10%. Precision Devices is expected to grow over 15% this year, while hearing-health margins remain above 50% gross and 40% EBITDA. Knowles plans to reduce debt and continue selective acquisitions.

$KNMed

Knowles Corp (KN): Results of Operations and Financial Condition

Knowles Corp (KN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q22026.htm EX-99.1 Document Exhibit 99.1 Financial Contact: Sarah Cook Knowles Investor Relations Email: investorrelations@knowles.com Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026 Q2 Revenues Increased 14% on a Year over Year Basi

$UNFIMedAI 8/10

United Natural Foods (UNFI) Calls the Bottom and Guides for Growth Again

United Natural Foods (UNFI) reported Q4 adjusted EPS of $0.69, beating estimates, but revenue of $7.64B missed expectations. The company guided fiscal 2027 sales to $31.2B-$31.8B, up from $31.15B in 2026. Adjusted EBITDA rose 27% to $701M, and free cash flow hit a record $323M. Management expects fiscal 2027 adjusted EPS of $3.00-$3.50. Hedge fund interest declined in Q2.

MedAI 8/10

LuxExperience B.V. Q4 2026 Earnings Call Summary

LuxExperience B.V. reported Q4 2026 earnings, highlighting EBITDA break-even 15 months post-acquisition. Mytheresa reached EUR 1 billion in sales, while NET-A-PORTER and MR PORTER returned to growth. YOOX cut losses by half. Management expects 2%-3% EBITDA margins in FY 2027 and EUR 4 billion in net sales by 2028. The company improved operational efficiency and strengthened its financial position.